Market Tracker

09/29 5:55am ET

United Therapeutics Corp (NASDAQ:UTHR)

118.67
Delayed Data
As of Sep 28
 -3.34 / -2.74%
Today’s Change
97.52
Today|||52-Week Range
164.04
-24.23%
Year-to-Date
5 Stocks with Exciting Price-to-Book Ratios
Sep 28 / Zacks.com - Paid Partner Content
3 Great Stocks You Can Buy on Sale
Sep 27 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close122.01
Today’s open121.76
Day’s range116.70 - 122.22
Volume884,269
Average volume (3 months)567,753
Market cap$5.3B
Dividend yield--
Data as of 09/28/2016

Growth & Valuation

Earnings growth (last year)+102.55%
Earnings growth (this year)+20.00%
Earnings growth (next 5 years)+0.70%
Revenue growth (last year)+13.76%
P/E ratio5.8
Price/Sales5.47
Price/Book3.51

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc-3.62-3.35%
ENDPEndo International P...-0.17-0.75%
TAROTaro Pharmaceutical ...-0.11-0.09%
OPKOPKO Health Inc-0.32-2.86%
Data as of 09/28/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$3.38
Annual revenue (last year)$1.5B
Annual profit (last year)$651.6M
Net profit margin44.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts